Stay updated on Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study history now indicates that results have been posted and additional core data sections (adverse events, baseline characteristics, participant flow, outcome measures, and arms/interventions) are now available in the record, reflecting a more complete posting of trial data.SummaryDifference0.6%

- Check19 days agoChange DetectedThe footer revision text updated to Revision: v3.6.5, replacing Revision: v3.6.4, indicating a newer site build.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe study record history now shows that results have been submitted, replacing the previous 'No Results Posted' status. The page has been updated to revision v3.6.4, signaling a new version of the study history.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page footer now shows Revision: v3.6.3, replacing Revision: v3.6.2; this reflects a minor version update of the site's underlying platform.SummaryDifference0.0%

- Check62 days agoChange DetectedFooter version badge updated from v3.6.0 to v3.6.2, indicating an upgrade to the site's interface/version. This change does not alter study data, eligibility, or results on the page.SummaryDifference0.0%

- Check76 days agoChange DetectedRecruitment status updated to no longer look for participants, indicating enrollment has closed. The page history now lists revision v3.6.0 and removes the prior revision v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.